Generated July 2026 from current fund data.
Overview
CRCL is a stock in Circle Internet Group, a cryptocurrency and blockchain infrastructure company. CRY is an ETF that sells put options on a 2x leveraged daily tracker of CRCL, targeting to generate roughly double the income yield available from selling options directly on the underlying stock. The two are structurally distinct: one is the equity itself, the other is a synthetic-income strategy layered on top of it.
How they differ
The defining difference is strategy: CRCL is a buy-and-hold equity with no distributions, while CRY actively monetizes volatility through weekly put-option sales on a 2x leveraged derivative. CRY charges a 1.07% expense ratio and targets a 91.72% annualized distribution rate, making it a yield-focused instrument; CRCL offers none. CRY's leverage and options overlay expose it to concentrated tail risk and potential NAV erosion if Circle's volatility contracts or the leveraged instrument underperforms, whereas CRCL's risk is straightforward price appreciation or decline. CRY is tiny ($1.08M in AUM) and newly launched (April 2026), while CRCL is the underlying equity itself, newly public (June 2025).
Who each is best for
CRCL: Fits investors seeking exposure to Circle's blockchain business fundamentals and willing to tolerate equity price volatility without expecting current income; those with a longer time horizon who view the company's long-term growth potential as the primary return driver.
CRY: Designed for investors prioritizing near-term income over capital appreciation, comfortable with options mechanics and leveraged daily tracking, and accepting that high current distributions may entail principal erosion in certain market regimes.
Key risks to know
- NAV erosion at extreme distribution yields. A 91.72% annualized payout rate substantially exceeds typical equity earnings yields and suggests distributions rely heavily on return-of-capital treatment. This dynamic is likely to erode NAV over time, especially if Circle's underlying volatility declines or the leveraged instrument's daily reset drag compounds losses.
- 2x leverage and daily reset decay. CRY's use of a 2x leveraged daily tracker introduces path-dependent losses when volatility is high or markets oscillate; the daily rebalancing mechanism amplifies losses in sideways or downward periods and may underperform the underlying stock in such conditions.
- Concentration in a single microcap equity. Both securities track Circle alone, so CRCL's regulatory, operational, or competitive setbacks create binary downside for both. CRY compounds this with leverage and derivatives, magnifying drawdown severity.
- Options assignment and liquidity risk. CRY's small AUM ($1.08M) and reliance on put-option sales mean the fund faces liquidity constraints, assignment risk during market stress, and potential difficulty adjusting its hedge if Circle gaps down sharply.
- Crypto-sector regulatory uncertainty. Circle operates in a heavily regulated cryptocurrency and stablecoin space where changes to U.S. or international policy could impair the company's business model or market value, affecting both holdings directly.
Bottom line
CRCL offers direct equity exposure to Circle's business with no yield component; CRY wraps that exposure in a high-leverage, high-distribution options strategy designed to extract income weekly. If you're seeking growth and can tolerate no current distributions, CRCL aligns with that objective; if you prioritize current income and accept elevated principal risk in exchange for a 91.72% target yield, CRY's structure is built for that tradeoff. Either way, both are concentrated single-asset plays in an emerging and volatile sector. Past performance of either security does not predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
